Abstract:Antivirulence therapy by cell membrane coated nanoparticles has shown promise against bacterial infections. However, current approaches remain unsatisfactory when facing Escherichia coli (E. coli) infections, since the E. coli secretes multiple bacterial toxins including endotoxins and exotoxins that are challenging to eliminate simultaneously. What is worse, the absorptive scavengers normally rely on random contact of the diffuse toxins, which is not efficient. For the current cell membrane coated platform, the single type of cell membrane cannot fully meet the detoxing requirement facing multiple toxins. To address these problems, a polymyxin B (PMB)-modified, red blood cell (RBC)-mimetic hybrid liposome (P-RL) was developed. The P-RL was fabricated succinctly through fusion of PMB-modified lipids and the RBC membranes. By the strong interaction between PMB and the E. coli membrane, P-RL could attach and anchor to the E. coli; attributed to the fused RBC membrane and modified PMB, the P-RL could then efficiently neutralize both endotoxins and exotoxins from the toxin fountainhead. In vitro and in vivo results demonstrated the P-RL had a significant anchoring effect to E. coli. Moreover, compared with the existing RBC vesicles or PMB-modified liposomes, P-RL exhibited a superior therapeutic effect against RBC hemolysis, macrophage activation, and a mixed-toxin infection in mice. Potently, P-RL could inhibit E. coli O157:H7-induced skin damage, intestinal infection, and mouse death. Overall, the P-RL could potentially improve the detoxing efficiency and markedly expand the detoxification spectrum of current antivirulence systems, which provides different insights into drug-resistant E. coli treatment.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsnano.0c04800?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsnano.0c04800</a>.Figures S1–S19, methods and results of PMB lipid synthesis, expression of HlyA, neutralization of α-hemolysin and E. coli O157:H7 toxin, macrophage activation model, therapeutic effect of P-RL in mixed-toxin model, therapeutic effect of P-RL at different infection stages and degrees, therapeutic effect of P-RL on intestinal infection model, biocompatibility of P-RL (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c04800/suppl_file/nn0c04800_si_001.docx">DOCX</a>)This article has not yet been cited by other publications.

Tug-of-War between Covalent Binding and Electrostatic Interaction Effectively Killing E. coli without Detectable Resistance

Unique Aminothiazolyl Coumarins As Potential DNA and Membrane Disruptors Towards Enterococcus Faecalis

External lysis of Escherichia coli by a bacteriophage endolysin modified with hydrophobic amino acids

Bacteria - Anchoring Hybrid Liposome Capable of Absorbing Multiple Toxins for Antivirulence Therapy of Escherichia coli Infection

Suppression of planktonic and biofilm of Escherichia coli by the synergistic lantibiotics–polymyxins combinations

Dark Antimicrobial Mechanisms of Cationic Phenylene Ethynylene Polymers and Oligomers Against Escherichia Coli

Hyperbranched Polylysine Exhibits a Collaborative Enhancement of the Antibiotic Capacity to Kill Gram-Negative Pathogens

In Vitro Antimicrobial Synergistic Activity and the Mechanism of the Combination of Naringenin and Amikacin Against Antibiotic-Resistant Escherichia coli

Silver Nanoparticle-Aminogylcosides Conjugation for Enhanced Control of Pathogenic E. Coli O157:H7

The synergistic antibacterial activity and mechanism of colistin-oxethazaine combination against gram-negative pathogens

Synthesis, characterization and in vitro antibacterial mechanism study of two Keggin-type polyoxometalates

Bactericidal synergism between phage endolysin Ply2660 and cathelicidin LL-37 against vancomycin-resistant Enterococcus faecalis biofilms

Killing of gram-negative bacteria by lactoferrin and lysozyme

Repurposing cetylpyridinium chloride and domiphen bromide as phosphoethanolamine transferase inhibitor to combat colistin-resistant Enterobacterales

A Powerful Combination of Copper-Cysteamine Nanoparticles with Potassium Iodide for Bacterial Destruction

A pharmacodynamic investigation to assess the synergism of orbifloxacin and propyl gallate against Escherichia coli

Boric Acid-Functionalized Carbon Dots as a High-Performance Antibacterial Agent against Escherichia coli

Dynamic covalent nano-networks comprising antibiotics and polyphenols orchestrate bacterial drug resistance reversal and inflammation alleviation

Molecular responses during bacterial filamentation reveal inhibition methods of drug- resistant bacteria

Bactericidal synergism between engineered endolysin Lysin1902 and tea polyphenols against Escherichia coli O157:H7 in various food products

2-Aminoimidazole Analogs Target PhoP Altering DNA Binding Activity and Affect Outer Membrane Stability in Gram-Negative Bacteria